WebDisclosure WebDisclosure
Basculer en Français
11296 Companies
251050 Keywords
179984 Articles
136900 Press releases
Headlines Articles Press releases Hedia ApS Remove
  1. Home
  2. Companies
  3. Hedia ApS
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/22/2026 at 10:10, 1 month 17 days ago

    Hedia Gains Approval to Expand Diabetes App to Pediatric Care

    Regulatory Approval Medical Device Regulation Digital Health Platforms Pediatric Diabetes Care Insulin Regimen Support
  • BRIEF

    published on 09/22/2026 at 10:10, 1 month 17 days ago

    Hedia obtient l'autorisation d'étendre son application pour le diabète aux soins pédiatriques.

    Plateformes De Santé Numérique Approbation Réglementaire Réglementation Des Dispositifs Médicaux Soins Du Diabète Pédiatrique Soutien Au Traitement Par Insuline
  • PRESS RELEASE

    published on 09/22/2026 at 10:05, 1 month 17 days ago

    Hedia Secures Regulatory Approval to Expand Digital Diabetes Care to Pediatric Patients

    Hedia secures regulatory approval for expanding digital diabetes care to pediatric patients, enabling broader insulin regimen support and enhanced device connectivity
    Regulatory Approval MDR Certification Pediatric Patients Hedia Digital Diabetes Care
    Logo of Hedia ApS
Accesswire
  • Published on 11/09/2026 at 12:30, 19 minutes ago

    Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile

  • Published on 11/06/2026 at 22:15, 2 days 14 hours ago

    Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders

  • Published on 11/06/2026 at 13:00, 2 days 23 hours ago

    Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska

  • Published on 11/06/2026 at 12:30, 3 days ago

    Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming

  • Published on 11/06/2026 at 12:30, 3 days ago

    Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights

View all ACCESSWIRE
EQS Group
  • Published on 11/09/2026 at 12:20, 29 minutes ago

    Recommended Cash Offer for Irish Residential Properties REIT plc

  • Published on 11/09/2026 at 12:15, 34 minutes ago

    Huawei Chronicles 30 Years of Wireless Innovation in a Documentary for the First Time

  • Published on 11/09/2026 at 11:05, 1 hour 44 minutes ago

    Velvet, mirrors and rooms upstairs: inside Lisbon's Pensão Amor

  • Published on 11/09/2026 at 11:05, 1 hour 44 minutes ago

    THE 50 BEST VINEYARDS REVEALS THE 51-100 LIST FOR 2026

  • Published on 11/09/2026 at 11:00, 1 hour 49 minutes ago

    LINXAI Robotics Claims Gold and Two Bronzes at First CMG World Robot Mount Tai Competition

View all EQS
Les Echos
  • Published on 11/09/2026 at 10:32, 2 hours 17 minutes ago

    Disclosure of shares outstanding and voting rights - 09.11.2026

  • Published on 11/09/2026 at 10:32, 2 hours 17 minutes ago

    Déclaration nombre d'actions et droits de vote - 09.11.2026

  • Published on 11/09/2026 at 07:00, 5 hours 49 minutes ago

    bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus

  • Published on 11/09/2026 at 07:00, 5 hours 49 minutes ago

    BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA

  • Published on 11/09/2026 at 07:00, 5 hours 49 minutes ago

    Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy